Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ReShape Lifesciences, Inc. - Common Stock (NQ:RSLS)

0.3603 -0.0266 (-6.88%)
Streaming Delayed Price Updated: 11:49 AM EDT, Mar 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 359,831
Open 0.3850
Bid (Size) 0.3602 (1)
Ask (Size) 0.3739 (40)
Prev. Close 0.3869
Today's Range 0.3532 - 0.3950
52wk Range 0.3867 - 29.00
Shares Outstanding 6,166,554
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, AVTE, RSLS on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
RESHAPE LIFESCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ReShape Lifesciences Inc. - RSLS
From Kahn Swick & Foti, LLC
Via Business Wire

Performance

YTD
-92.1%
-92.1%
1 Month
-65.0%
-65.0%
3 Month
-92.0%
-92.0%
6 Month
-93.6%
-93.6%
1 Year
-96.2%
-96.2%

More News

Read More
ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
From ReShape Lifesciences Inc
Via GlobeNewswire
ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Growth Last Week
Via Stocktwits
On Tuesday, there are stocks with unusual volume. Let's take a look.
Via Chartmill
ReShape Lifesciences® Signs Distribution Agreement in Canada With Liaison Medical for its Next-Generation Lap-Band® 2.0 FLEX
From ReShape Lifesciences Inc
Via GlobeNewswire
On Friday, there are stocks with unusual volume. Let's take a look.
Via Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill
Top movers analysis one hour before the close of the markets on 2025-02-19: top gainers and losers in today's session.
Via Chartmill
On Wednesday, there are stocks with unusual volume. Let's take a look.
Via Chartmill
Here are the top movers in Wednesday's session.
Via Chartmill
Wednesday's session: gap up and gap down stocks
Via Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
Why Global Blue Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why GCL Global Holdings Shares Are Trading Higher By Around 107%; Here Are 20 Stocks Moving Premarket
Via Benzinga
ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering
From ReShape Lifesciences Inc
Via GlobeNewswire
ReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology
From ReShape Lifesciences Inc
Via GlobeNewswire
ReShape Lifesciences® Provides Update on Merger Agreement With Vyome Therapeutics and Asset Purchase Agreement With Biorad Medisys
From ReShape Lifesciences Inc
Via GlobeNewswire
ReShape Lifesciences® Reports Third Quarter Ended September 30, 2024 Financial Results and Provides Corporate Update
From ReShape Lifesciences Inc
Via GlobeNewswire
ReShape Lifesciences® to Announce Financial Results for the Third Quarter Ended September 30, 2024, and Provide Corporate Update
From ReShape Lifesciences Inc
Via GlobeNewswire
Earnings Scheduled For November 14, 2024
Via Benzinga
ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX
From ReShape Lifesciences Inc
Via GlobeNewswire
ReShape Lifesciences® Receives NIH Supplementary Grant with the University of Southern California’s Center for Autonomic Nerve Recording and Stimulation Systems (CARSS) to Further Develop Next-Generation Electrodes for ReShape’s Proprietary Diabetes
From ReShape Lifesciences Inc
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga

Frequently Asked Questions

Is ReShape Lifesciences, Inc. - Common Stock publicly traded?
Yes, ReShape Lifesciences, Inc. - Common Stock is publicly traded.
What exchange does ReShape Lifesciences, Inc. - Common Stock trade on?
ReShape Lifesciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ReShape Lifesciences, Inc. - Common Stock?
The ticker symbol for ReShape Lifesciences, Inc. - Common Stock is RSLS on the Nasdaq Stock Market
What is the current price of ReShape Lifesciences, Inc. - Common Stock?
The current price of ReShape Lifesciences, Inc. - Common Stock is 0.3603
When was ReShape Lifesciences, Inc. - Common Stock last traded?
The last trade of ReShape Lifesciences, Inc. - Common Stock was at 03/31/25 11:49 AM ET
What is the market capitalization of ReShape Lifesciences, Inc. - Common Stock?
The market capitalization of ReShape Lifesciences, Inc. - Common Stock is 2.22M
How many shares of ReShape Lifesciences, Inc. - Common Stock are outstanding?
ReShape Lifesciences, Inc. - Common Stock has 2M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.